MSM satisfies first Debiopharm milestone
04/10/2013
We are pleased to announce that MSM has satisfied the first pre-clinical milestones in its
collaboration with Debiopharm of Lausanne Switzerland. Debiopharm has determined that
antibodies generated by MSM have satisfied the target molecular profile as stipulated in our
collaboration agreement and the project has moved into the next phase of development.
About MSM Protein Technologies
MSM Protein Technologies is a closely held drug discovery company that specializes in
discovering antibodies targeting complex cell surface receptors such as G Protein- Coupled
Receptors (GPCRs). Using proprietary technologies originating at the Dana Farber Institute and
developed within MSM, the company is able to overexpress the cell surface proteins in their
native conformation, maximizing the possibility of discovering functional antibodies.
For more information: [email protected] 781-321-3322
© Copyright 2005-2013 MSM Protein Technologies, Inc. • 10-A Roessler Road • Woburn, MA 01801
Phone: (781) 321-3322 • Email: [email protected]